Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript

SA Transcripts 161.76K Followers Follow Absci Corporation ( ABSI ) Q2 2026 Earnings Call August 11, 2026 4:30 PM EDT Company Participants Alexander Khan - CVP of Finance & Head of Investor Relations Sean McClain - Founder, CEO, President & Director Ransi Somaratne - Chief Medical Officer Zachariah Jonasson - Chief Business Officer & CFO Conference Call Participants Lut Ming Cheng - JPMorgan Chase & Co, Research Division Brendan Smith - TD Cowen, Research Division Vamil Divan - Guggenheim Securities, LLC, Research Division Kambiz Yazdi - BTIG, LLC, Research Division Gil Blum - Needham & Company, LLC, Research Division Presentation Operator Thank you. Good day and thank you for standing by. Welcome to the Absci Second Quarter Business Update. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Alex Khan, Corporate Vice President and Investor Relations. Please go ahead. Alexander Khan CVP of Finance & Head of Investor Relations Thank you. Earlier today, Absci released financial and operating results for the quarter ended June 30, 2026. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. An archived webcast of this call will be available for replay on Absci's Investor Relations website at investors.absci.com for at least 90 days after this call. Joining me today are Sean McClain, Absci's Founder and CEO; Zach Jonasson, Chief Financial Officer and Chief Business Officer; and Ransi Somaratne, Chief Medical Officer, Head of R&D. Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements.